drugset / Trial / NCT01511549

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

NCT01511549 ↗

Phase 1 Completed 24 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary Objective: To assess the safety and tolerability of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses Secondary Objective: To assess the pharmacokinetics of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses

Timeline

Start
2012-01
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject SAR113945 Unknown — Other

Indications